Informações:
Falhas:
ID
40391
Descrição
Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management; ODM derived from: https://clinicaltrials.gov/show/NCT01766752
Link
https://clinicaltrials.gov/show/NCT01766752
Palavras-chave
Versões (3)
- 19/01/2019 19/01/2019 -
- 17/04/2020 17/04/2020 -
- 17/04/2020 17/04/2020 - Sarah Riepenhausen
Titular dos direitos
Medical University of Graz
Transferido a
17 de abril de 2020
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes NCT01766752
Eligibility Type 2 Diabetes NCT01766752
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT01766752
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Informed consent
Item
informed consent obtained after being advised of the nature of the study
boolean
C0021430 (UMLS CUI [1])
Age
Item
male or female aged 18 - 90 years (both inclusive)
boolean
C0001779 (UMLS CUI [1])
Type 2 DM treated with: diet, oral or injected antidiabetics, insulin, single or combined
Item
type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
boolean
C0011860 (UMLS CUI [1])
C0011878 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0935929 (UMLS CUI [4,1])
C1828121 (UMLS CUI [4,2])
C0021641 (UMLS CUI [5])
C3274787 (UMLS CUI [6,1])
C0205195 (UMLS CUI [6,2])
C0011878 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0935929 (UMLS CUI [4,1])
C1828121 (UMLS CUI [4,2])
C0021641 (UMLS CUI [5])
C3274787 (UMLS CUI [6,1])
C0205195 (UMLS CUI [6,2])
Renal insufficiency Creatinine measurement (serum)
Item
impaired renal function (serum creatinine ≥3.0mg/dl)
boolean
C1565489 (UMLS CUI [1,1])
C0201976 (UMLS CUI [1,2])
C0201976 (UMLS CUI [1,2])
Disease interferes with study protocol | Disease risk for patient safety
Item
any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1113679 (UMLS CUI [2,3])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1113679 (UMLS CUI [2,3])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Mental disorder | Informed Consent incapable
Item
any mental condition rendering the patient incapable of giving his consent
boolean
C0004936 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1550518 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C1550518 (UMLS CUI [1,3])
Terminal illness
Item
terminally ill patients
boolean
C0679247 (UMLS CUI [1])
Recent trial participation
Item
participation in a trial within 3 months prior to this trial
boolean
C2348568 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
Insulin allergy, known or suspected
Item
known or suspected allergy to insulin
boolean
C0571622 (UMLS CUI [1])
C0571622 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0571622 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])